CRM vs PLTR: Which Is the Better Buy?

Side-by-side comparison of Salesforce, Inc. and Palantir Technologies Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Salesforce, Inc. ยท Technology
$236.42
+11.6% upside to fair value
Med Conviction Grade B High Quality
VS
Palantir Technologies Inc. ยท Technology
$189.67
+2.4% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
CRM has more upside to fair value (+11.6%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric CRM PLTR
Current Price $236.42 $189.67
Fair Value Estimate $263.88 $194.30
Upside to Fair Value +11.6% +2.4%
Market Cap $193.6B $435.5B
Forward P/E โ€” โ€”
EV / EBITDA 14.4x 139.9x
Price / Sales 4.4x 70.7x
Price / FCF 12.8x 135.3x
Revenue Growth YoY +10.8% +92.8%
Gross Margin 77.3% 84.8%
Operating Margin 21.4% 42.8%
Return on Equity 20.2% 37.5%
Dividend Yield 0.73% 0%
FCF Yield 7.82% 0.74%
Analyst Consensus Buy Hold
Investment Thesis
CRM โ€” Salesforce, Inc.
Salesforce is the leading enterprise customer relationship management platform, spanning Sales, Service, Platform, Marketing, Commerce, Tableau, MuleSoft, and Slack under the Customer 360 umbrella, with 83,334 employees and a business that converts $53.65 of revenue per share into $18.48 of free cash flow per share. Business quality is high: TTM gross margin of 77.3%, TTM operating margin of 21.4โ€ฆ
PLTR โ€” Palantir Technologies Inc.
Palantir Technologies Inc. is a software infrastructure company founded in 2003 and headquartered in Denver that builds and deploys Gotham for intelligence and defense workflows, Foundry as a central data operating system for enterprises, Apollo for software delivery across environments, and its Artificial Intelligence Platform (AIP) for unified access to open-source, self-hosted, and commercial โ€ฆ
Accumulation Zones
Metric CRM PLTR
Zone Low $197.91 $145.73
Zone High $224.30 $165.16
In Buy Zone? No No
โ† CRM Research    PLTR Research โ†’    All Research